FEDERAL EXPERTS’ ADVICE ON HPV VACCINE COULD LEAVE ADULTS CONFUSED
August 08, 2019 / Michelle Andrews
Vaccination decisions are usually pretty straightforward. People either meet the criteria for the vaccine based on their age or other factors or they don’t. But when a federal panel recently recommended an update to the human papillomavirus (HPV) vaccine guidelines, it left a lot of uncertainty. The panel recommended that men and women between ages 27 and 45 decide in discussion with their health care providers whether the HPV vaccine makes sense for them. But some public health advocates criticize that advice because it doesn’t provide doctors and patients clear guidance about who in this expansive age group are good candidates. They worry that many people may get immunized who won’t benefit, adding needless cost to the health care system and possibly shortchanging people overseas, where the vaccine is in short supply.